PubMed Health⌕ Search

Biomedical subjects

Yiliang Zhu

Publications and source records attributed to Yiliang Zhu.

4 recordsLinked to original sources

Initial evaluation of the early aberration reporting system--Florida.

INTRODUCTION: In recent years, many syndromic surveillance systems have been deployed around the United States for the early detection of biologic terrorism-related and naturally occurring outbreaks. These systems and the associated aberration detection methods need to be evaluated. OBJECTIVE: This study evaluated several detection methods of the Early Aberration Reporting System (EARS) under serially correlated syndromic data and to demonstrated the need for calibrating these methods. METHODS: In an initial evaluation of the Syndromic Tracking and Reporting System in Hillsborough County, Florida, serially correlated syndromic data were simulated using statistical models in conjunction with real syndromic data. The detection methods were tested against two patterns of simulated outbreaks. They were compared using a conditional average run length and a receiver operating characteristic curve under defined patterns of detection. RESULTS: Increasing serial correlation inflates the false alarm rate and elevates sensitivity. Among the detection methods in EARS, C2 and P-chart have the best overall receiver operating characteristic curve within the context of the simulations. C2 is least affected by the serial correlation, the outbreak type, and the defined patterns of detection signal. CONCLUSION: Evaluation of the detection methods needs to be adaptable to the constantly changing nature of syndromic surveillance. Deployment of EARS and other methods requires adjusting the false alarm rate and sensitivity in accordance with the syndromic data, the operating resources, and the objectives of the local system. For timely detection, C2 is superior to other methods, including C3, under the simulation conditions. P-chart is the most sensitive when the serial correlation is negligible.

Algorithms↗

Trajectory of systolic blood pressure in children and adolescents.

PURPOSE: Rapid height and weight changes during childhood contribute markedly to blood-pressure change during children's physical growth. This article evaluates the differences in systolic blood pressure (SBP) growth or changes between four gender-ethnic groups: African American males (AM), Caucasian males (CM), African American females (AF), and Caucasian females (CF). METHODS: Subjects 6-9 years old at entry (n = 1302) were followed for 12 years. The repeated-measure data of SBP were analyzed using the Gompertz growth model with random coefficients. RESULTS: Mean SBP (mmHg) at age 6 years was lowest in African American girls (82.23 +/- 0.76) and highest in Caucasian boys (102.83 +/- 0.5). And for both ethnic groups, girls had lower levels at which SBP growth stopped. The peak growth ages (years) also differed by group: 9.30 +/- 0.73, 9.91 +/- 0.28, 10.00 +/- 0.82, and 10.60 +/- 0.22 for African American girls, African American boys, Caucasian girls and Caucasian boys, respectively. CONCLUSION: SBP growth differed among gender-ethnic groups with respect to mean SBP level at age 6, the level at which SBP growth stops and the mean age at which SBP growth rate was at its peak.

Adolescent↗

Analyses of neurobehavioral screening data: dose-time-response modeling of continuous outcomes.

Neurotoxic effects are a non-cancer endpoint for health risk, and neurobehavioral screening tests can serve as a first tier investigation of neurotoxicity [US EPA, Federal Register 63 (1998) 26926]. Analysis of neurobehavioral screening data such as those of the functional observational battery (FOB) traditionally relies on analysis of variance (ANOVA). ANOVA is designed to detect whether there are dose-effects, but does not model the underlying dose-response relationship and subsequent risk assessment fails to utilize the shape of the underlying dose-response. In contrast, dose-response modeling interpolates toxic effects between experimental points, and permits prediction of toxic effects within the experimental range. Additionally it is also a prerequisite for estimating a benchmark dose. This paper discusses dose-time-response modeling of longitudinal neurotoxicity data and illustrates the methods using three continuous FOB outcomes from an EPA study involving acute exposure to triethyltin (TET). Several mathematical functions are presented as candidate dose-time-response models. The use of random effects is discussed to characterize inter-subject variation. The results indicate that it is feasible to use simple mathematical functions to model empirical dose-time-response observed in existing longitudinal neurotoxicological data. Further research is needed on the types of design and data required to reliably approximate the true underlying dose-time-response.

Behavior↗

Analyses of neurobehavioral screening data: benchmark dose estimation.

Zhu et al. (Zhu, Y., Wessel, M., Liu, T., Moser, V.C., 2005. Analyses of neurobehavioral screening data: dose-time-response modeling of continuous outcomes. Regul. Toxicol. Pharmacol. 41, 240-255) have recently applied dose-time-response models to longitudinal or time-course neurotoxicity data, and have illustrated the modeling process using continuous data from a functional observational battery (FOB). Following the work of these authors, the purpose of this paper is to show that the benchmark dose (BMD) method for single time point dose-response data can be generalized and applied to longitudinal data such as those generated in neurotoxicity studies. We propose a statistical procedure called bootstrap method for computing the lower confidence limits for the BMD. We demonstrate the method using three previously published FOB datasets of triethyltin (Moser, V.C., Becking, G.C., Cuomo, V., Frantik, E., Kulig, B., MacPhail, R.C., Tilson, H.A., Winneke, G., Brightwell, W.S., DeSalvia, M.A., Gill, M.W., Haggerty, G.C., Hornychova, M., Lammers, J., Larsson, J., McDaniel, K.L., Nelson, B.K., Ostergaard, G., 1997a. The IPCS study on neurobehavioral screening methods: results of chemical testing. Neurotoxicology 18, 969-1056.) and the models of Zhu et al. (Zhu, Y., Wessel, M., Liu, T., Moser, V.C., 2005. Analyses of neurobehavioral screening data: dose-time-response modeling of continuous outcomes. Regul. Toxicol. Pharmacol. 41, 240-255).

Algorithms↗